The global over-the-counter veterinary drug market is expected to grow at a CAGR of 4.5% during the forecast period, to reach USD 3.2 billion by 2030. The growth of this market is driven by the increasing demand for animal health products and rising awareness about animal welfare among consumers. The top three segments in this market are topical drugs, oral drugs, and injectable drugs. Oral drugs accounted for the largest share in 2018 due to their wide range of applications such as treatment of pain, inflammation, fever reduction, and prevention or control of disease symptoms. North America was the leading region in 2018 with a share of 39%. This can be attributed to high adoption rates among pet owners owing to increased awareness about animal welfare and availability of veterinary services at affordable prices in this region.
- The global pet population is growing at a rapid rate, which is increasing the demand for veterinary drugs.
- The increase in the number of pets in households has led to an increase in the number of pets that are being treated with veterinary drugs.
- The increased awareness about animal welfare and animal rights has led to an increased demand for veterinary drugs, as people are more likely to take their animals to a vet when they have health problems or injuries than they were before this awareness was raised.
- There is a higher incidence of diseases among animals than there used to be, which means that there is also a higher demand for veterinary drugs because these diseases need treatment with medication and other treatments like surgery or physical therapy.
- There are more vets now than there used to be, which means that there are more vets who can prescribe medications and other treatments for animals who need them, leading to an increase in the use of these medications and treatments.
Industry Growth Insights published a new data on “Over-The-Counter Veterinary Drug Market”. The research report is titled “Over-The-Counter Veterinary Drug Market research by Types (Topical Drug, Oral Drug, Injectable Drug), By Applications (Veterinary Hospital, Veterinary Clinic, Others), By Players/Companies Merck, Zoetis, Eli Lilly, Virbac, Bayer, Sanofi, Soparfin SCA, C. H. Boehringer Sohn, Dechra Pharmaceuticals”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Over-The-Counter Veterinary Drug Market Research Report
By Type
Topical Drug, Oral Drug, Injectable Drug
By Application
Veterinary Hospital, Veterinary Clinic, Others
By Companies
Merck, Zoetis, Eli Lilly, Virbac, Bayer, Sanofi, Soparfin SCA, C. H. Boehringer Sohn, Dechra Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Over-The-Counter Veterinary Drug Market Report Segments:
The global Over-The-Counter Veterinary Drug market is segmented on the basis of:
Types
Topical Drug, Oral Drug, Injectable Drug
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Veterinary Hospital, Veterinary Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Zoetis
- Eli Lilly
- Virbac
- Bayer
- Sanofi
- Soparfin SCA
- C. H. Boehringer Sohn
- Dechra Pharmaceuticals
Highlights of The Over-The-Counter Veterinary Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Topical Drug
- Oral Drug
- Injectable Drug
- By Application:
- Veterinary Hospital
- Veterinary Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Over-The-Counter Veterinary Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Over-the-counter veterinary drugs are medications that can be purchased without a prescription from most pharmacies. These medications are typically used to treat common pet illnesses and injuries, such as fleas, ticks, and ear infections.
Some of the major companies in the over-the-counter veterinary drug market are Merck, Zoetis, Eli Lilly, Virbac, Bayer, Sanofi, Soparfin SCA, C. H. Boehringer Sohn, Dechra Pharmaceuticals.
The over-the-counter veterinary drug market is expected to grow at a compound annual growth rate of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Over-The-Counter Veterinary Drug Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Over-The-Counter Veterinary Drug Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Over-The-Counter Veterinary Drug Market - Supply Chain
4.5. Global Over-The-Counter Veterinary Drug Market Forecast
4.5.1. Over-The-Counter Veterinary Drug Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Over-The-Counter Veterinary Drug Market Size (000 Units) and Y-o-Y Growth
4.5.3. Over-The-Counter Veterinary Drug Market Absolute $ Opportunity
5. Global Over-The-Counter Veterinary Drug Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Over-The-Counter Veterinary Drug Market Size and Volume Forecast by Type
5.3.1. Topical Drug
5.3.2. Oral Drug
5.3.3. Injectable Drug
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Over-The-Counter Veterinary Drug Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Over-The-Counter Veterinary Drug Market Size and Volume Forecast by Application
6.3.1. Veterinary Hospital
6.3.2. Veterinary Clinic
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Over-The-Counter Veterinary Drug Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Over-The-Counter Veterinary Drug Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Over-The-Counter Veterinary Drug Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Over-The-Counter Veterinary Drug Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Over-The-Counter Veterinary Drug Demand Share Forecast, 2019-2026
9. North America Over-The-Counter Veterinary Drug Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Over-The-Counter Veterinary Drug Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Over-The-Counter Veterinary Drug Market Size and Volume Forecast by Application
9.4.1. Veterinary Hospital
9.4.2. Veterinary Clinic
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Over-The-Counter Veterinary Drug Market Size and Volume Forecast by Type
9.7.1. Topical Drug
9.7.2. Oral Drug
9.7.3. Injectable Drug
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Over-The-Counter Veterinary Drug Demand Share Forecast, 2019-2026
10. Latin America Over-The-Counter Veterinary Drug Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Over-The-Counter Veterinary Drug Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Over-The-Counter Veterinary Drug Market Size and Volume Forecast by Application
10.4.1. Veterinary Hospital
10.4.2. Veterinary Clinic
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Over-The-Counter Veterinary Drug Market Size and Volume Forecast by Type
10.7.1. Topical Drug
10.7.2. Oral Drug
10.7.3. Injectable Drug
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Over-The-Counter Veterinary Drug Demand Share Forecast, 2019-2026
11. Europe Over-The-Counter Veterinary Drug Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Over-The-Counter Veterinary Drug Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Over-The-Counter Veterinary Drug Market Size and Volume Forecast by Application
11.4.1. Veterinary Hospital
11.4.2. Veterinary Clinic
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Over-The-Counter Veterinary Drug Market Size and Volume Forecast by Type
11.7.1. Topical Drug
11.7.2. Oral Drug
11.7.3. Injectable Drug
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Over-The-Counter Veterinary Drug Demand Share, 2019-2026
12. Asia Pacific Over-The-Counter Veterinary Drug Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Over-The-Counter Veterinary Drug Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Over-The-Counter Veterinary Drug Market Size and Volume Forecast by Application
12.4.1. Veterinary Hospital
12.4.2. Veterinary Clinic
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Over-The-Counter Veterinary Drug Market Size and Volume Forecast by Type
12.7.1. Topical Drug
12.7.2. Oral Drug
12.7.3. Injectable Drug
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Over-The-Counter Veterinary Drug Demand Share, 2019-2026
13. Middle East & Africa Over-The-Counter Veterinary Drug Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Over-The-Counter Veterinary Drug Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Over-The-Counter Veterinary Drug Market Size and Volume Forecast by Application
13.4.1. Veterinary Hospital
13.4.2. Veterinary Clinic
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Over-The-Counter Veterinary Drug Market Size and Volume Forecast by Type
13.7.1. Topical Drug
13.7.2. Oral Drug
13.7.3. Injectable Drug
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Over-The-Counter Veterinary Drug Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Over-The-Counter Veterinary Drug Market: Market Share Analysis
14.2. Over-The-Counter Veterinary Drug Distributors and Customers
14.3. Over-The-Counter Veterinary Drug Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Merck
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Zoetis
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Eli Lilly
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Virbac
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bayer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sanofi
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Soparfin SCA
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. C. H. Boehringer Sohn
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Dechra Pharmaceuticals
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook